Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19By / 23/11/2023 Shanghai Junshi Biosciences Co., Ltd announced a new publication in the Lancet Infectious Diseases.
